18.36
price up icon3.46%   0.6125
 
loading
Schlusskurs vom Vortag:
$17.75
Offen:
$17.76
24-Stunden-Volumen:
1.30M
Relative Volume:
0.60
Marktkapitalisierung:
$1.57B
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-15.30
EPS:
-1.2
Netto-Cashflow:
$-52.85M
1W Leistung:
+25.79%
1M Leistung:
+33.27%
6M Leistung:
+27.89%
1J Leistung:
+61.95%
1-Tages-Spanne:
Value
$17.68
$18.44
1-Wochen-Bereich:
Value
$14.25
$18.44
52-Wochen-Spanne:
Value
$8.26
$19.41

Liquidia Corp Stock (LQDA) Company Profile

Name
Firmenname
Liquidia Corp
Name
Telefon
919.328.4400
Name
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
Mitarbeiter
170
Name
Twitter
@Liquidia_Inc
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
LQDA's Discussions on Twitter

Vergleichen Sie LQDA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LQDA
Liquidia Corp
18.35 1.42B 17.49M -78.50M -52.85M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.69 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
570.82 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.14 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
588.61 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.96 31.99B 3.81B -644.79M -669.77M -6.24

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-19 Herabstufung Oppenheimer Perform → Underperform
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-08-19 Hochstufung Raymond James Outperform → Strong Buy
2024-08-16 Eingeleitet Raymond James Outperform
2024-06-25 Eingeleitet Oppenheimer Perform
2024-01-05 Bestätigt Needham Buy
2022-09-19 Fortgesetzt Wedbush Underperform
2022-09-01 Herabstufung Wedbush Neutral → Underperform
2022-07-22 Eingeleitet Ladenburg Thalmann Buy
2022-05-31 Eingeleitet BTIG Research Buy
2022-05-26 Eingeleitet BofA Securities Buy
2020-12-04 Eingeleitet H.C. Wainwright Buy
2020-11-20 Herabstufung Wedbush Outperform → Neutral
2018-11-08 Fortgesetzt Jefferies Buy
2018-09-05 Eingeleitet Wedbush Outperform
2018-08-20 Eingeleitet Jefferies Buy
2018-08-20 Eingeleitet Needham Buy
Alle ansehen

Liquidia Corp Aktie (LQDA) Neueste Nachrichten

pulisher
Jul 23, 2025

Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling - MSN

Jul 23, 2025
pulisher
Jul 21, 2025

What analysts say about Liquidia Corporation stockFree Market Volatility Navigation Tips - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

Does Liquidia Corporation stock pay reliable dividendsTargeted 200 Percent Gain - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Liquidia Corp: chief human resource officer Krepp sells $38k in stock - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Liquidia Corp: chief human resource officer Krepp sells $38k in stock By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Liquidia Corporation stock price move sharplyPredictable High Return Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Liquidia Corporation stock attracts strong analyst attentionPotential Rocket List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Liquidia Corporation stock performs during market volatility2x Return Forecast - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

When Can We Expect A Profit From Liquidia Corporation (NASDAQ:LQDA)? - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week - Yahoo Finance

Jul 10, 2025
pulisher
Jul 09, 2025

Liquidia Signs 70,000 SF Life Sciences Lease at Pathway Triangle in Morrisville, North Carolina - REBusinessOnline

Jul 09, 2025
pulisher
Jul 03, 2025

DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC FilingForm 3 - Stock Titan

Jul 03, 2025
pulisher
Jul 02, 2025

Liquidia Technologies Appoints Dana Boyle as Chief Accounting Officer - The Globe and Mail

Jul 02, 2025
pulisher
Jul 01, 2025

Liquidia appoints Dana Boyle as chief accounting officer - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

What Next For Liquidia After Launch? (NASDAQ:LQDA) - Seeking Alpha

Jun 30, 2025
pulisher
Jun 27, 2025

BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQ - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQDA Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 26, 2025

Bearish Sentiment Surrounds Liquidia (LQDA) with Elevated Put Ac - GuruFocus

Jun 26, 2025
pulisher
Jun 23, 2025

Liquidia Attacks UTC’s Tyvaso Drug Patent at Bench Trial Opening - Bloomberg Law News

Jun 23, 2025
pulisher
Jun 20, 2025

Billion-dollar life sciences campus finally signs first tenant - The Business Journals

Jun 20, 2025
pulisher
Jun 19, 2025

Liquidia leases space for manufacturing facility near headquarters - Business North Carolina

Jun 19, 2025
pulisher
Jun 18, 2025

Liquidia Technologies Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 12, 2025

Wells Fargo Raises Price Target for Liquidia (LQDA) to $25 | LQD - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Liquidia (LQDA): B of A Securities Lowers Price Target to $23 | LQDA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

# Raymond James reiterates Strong Buy on Liquidia stock amid competition - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

# Raymond James reiterates Strong Buy on Liquidia stock amid competition By Investing.com - Investing.com UK

Jun 11, 2025
pulisher
Jun 10, 2025

Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily

Jun 10, 2025
pulisher
Jun 10, 2025

Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings | LQDA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Phase II home run: Insmed’s TPIP hits hypertension endpoints - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 06, 2025

Treprostinil Saga Continues - JD Supra

Jun 06, 2025
pulisher
Jun 04, 2025

Liquidia at Jefferies Conference: Strategic Moves in PAH Market - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

BTIG Raises Liquidia Price Target Following YUTREPIA Approval - Insider Monkey

Jun 03, 2025
pulisher
Jun 02, 2025

Judge Denies UTC Bid To Block Liquidia's Lung Drug - Law360

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia (LQDA) Stock Price Target Raised by Analyst | LQDA Stoc - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Raymond James maintains strong buy on Liquidia stock following court ruling By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

BTIG raises Liquidia stock price target following FDA approval By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Raymond James maintains strong buy on Liquidia stock following court ruling - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

BTIG raises Liquidia stock price target following FDA approval - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia Beats UTC Bid to Block Launch of Lung Drug Yutrepia - Bloomberg Law News

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia stock rises following YUTREPIA shipment news By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia stock rises following YUTREPIA shipment news - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Needham raises Liquidia Technologies stock price target after court ruling By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Needham raises Liquidia Technologies stock price target after court ruling - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia (LQDA) Gets Price Target Boost from Needham | LQDA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia Set to Make First Commercial Shipment of Yutrepia for Pulmonary Hypertension - marketscreener.com

Jun 02, 2025

Finanzdaten der Liquidia Corp-Aktie (LQDA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Liquidia Corp-Aktie (LQDA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schundler Russell
General Counsel
Jul 14 '25
Sale
14.28
7,836
111,898
577,977
Saggar Rajeev
Chief Medical Officer
Jul 14 '25
Sale
14.28
5,327
76,070
271,413
Moomaw Scott
Chief Commercial Officer
Jul 14 '25
Sale
14.28
4,797
68,501
223,231
Krepp Sarah
Chief Human Resource Officer
Jul 14 '25
Sale
14.28
2,673
38,170
142,499
Kaseta Michael
CFO and COO
Jul 14 '25
Sale
14.28
11,580
165,362
406,412
JEFFS ROGER
Chief Executive Officer
Jul 14 '25
Sale
14.28
20,252
289,199
1,038,560
JEFFS ROGER
Chief Executive Officer
Jul 14 '25
Sale
14.28
20,252
289,199
1,038,560
Boyle Dana
Chief Accounting Officer
Jul 14 '25
Sale
14.28
1,193
17,036
187,168
Adair Jason
Chief Business Officer
Jul 14 '25
Sale
14.28
2,576
36,785
193,634
Schundler Russell
General Counsel
Jun 04 '25
Sale
16.97
8,460
143,566
582,054
$23.62
price up icon 3.28%
$36.59
price up icon 1.62%
$103.43
price up icon 0.09%
$27.66
price down icon 1.21%
$113.95
price down icon 0.57%
biotechnology ONC
$296.05
price up icon 0.44%
Kapitalisierung:     |  Volumen (24h):